Results 171 to 180 of about 5,511,471 (226)

Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study. [PDF]

Int J Mol Sci
Silingardi M, Zappulo F, Dormi A, Pizzini AM, Donadei C, Cappuccilli M, Fantoni C, Zaccaroni S, Pizzuti V, Cilloni N, Tantillo S, Guidi A, Mancini R, La Manna G, Comai G.   +14 more
europepmc   +1 more source

A Disintegrin and Metalloprotease with Thrombospondin Motif, Member 13, and Von Willebrand Factor in Relation to the Duality of Preeclampsia and HIV Infection. [PDF]

Int J Mol Sci
Naidoo P, Naicker T.
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura in Pediatric Patients. [PDF]

Biomedicines
Shrestha N, Okpako E, Maitta RW.
europepmc   +1 more source

Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology. [PDF]

Am J Clin Pathol
Jacobs JW, Stuart MS, Tange JI, Leger RR, Ashrani AA, Chen D, Pruthi RK, Sridharan M, Seheult JN.   +8 more
europepmc   +1 more source

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP. [PDF]

Blood Adv
Postmus T, Schilder N, Ferreira de Santana J, Langerhorst P, Kaijen P, Coppo P, Joly BS, Veyradier A, Vanhoorelbeke K, Voorberg J.   +9 more
europepmc   +1 more source

Beyond the Limits of Conventional Coagulation Tests: A Comprehensive Overview of ACLF-Related Coagulopathies. [PDF]

J Clin Med
Kurpiewska D, Kośnik A, Bieliński K, Raszeja-Wyszomirska J.   +3 more
europepmc   +1 more source

Agents of shield: glycans mask antibody epitopes on ADAMTS13. [PDF]

Blood Adv
Kretz CA.
europepmc   +1 more source

A machine learning algorithm for peripheral artery disease prognosis using biomarker data

iScience
Summary: Peripheral artery disease (PAD) biomarkers have been studied in isolation; however, an algorithm that considers a protein panel to inform PAD prognosis may improve predictive accuracy.
Ben Li, Farah Shaikh, Abdelrahman Zamzam, Muzammil H. Syed, Rawand Abdin, Mohammad Qadura   +5 more
doaj  

Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy. [PDF]

Ann Hematol
Tanaka H, Sakai K, Tamura S, Shiwaku H, Nakamura J, Ueda Y, Bamba S, Nishikubo M, Nagai Y, Matsumoto M.   +9 more
europepmc   +1 more source

VWF-ADAMTS13 imbalance bridges infection to stroke. [PDF]

Blood Adv
Dong JF, Han C.
europepmc   +1 more source